Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
PRGO [NYSE]
Perrigo Company Public Limited Company
IndexS&P 500 P/E82.88 EPS (ttm)1.82 Insider Own0.10% Shs Outstand133.82M Perf Week8.52%
Market Cap20.19B Forward P/E17.82 EPS next Y8.47 Insider Trans-2.19% Shs Float132.72M Perf Month-0.17%
Income191.80M PEG7.34 EPS next Q1.60 Inst Own76.40% Short Float2.41% Perf Quarter13.58%
Sales3.88B P/S5.20 EPS this Y12.00% Inst Trans-1.32% Short Ratio2.48 Perf Half Y-2.37%
Book/sh64.01 P/B2.36 EPS next Y12.97% ROA9.20% Target Price168.80 Perf Year27.40%
Cash/sh4.61 P/C32.71 EPS next 5Y11.29% ROE16.10% 52W Range115.70 - 168.26 Perf YTD-1.57%
Dividend0.42 P/FCF54.04 EPS past 5Y26.20% ROI11.90% 52W High-10.35% Beta0.33
Dividend %0.28% Quick Ratio1.70 Sales past 5Y15.40% Gross Margin35.70% 52W Low30.37% ATR4.12
Employees9900 Current Ratio2.40 Sales Q/Q9.20% Oper. Margin15.60% RSI (14)54.99 Volatility2.36% 2.08%
OptionableYes Debt/Eq0.38 EPS Q/Q-69.50% Profit Margin22.70% Rel Volume0.85 Prev Close147.88
ShortableYes LT Debt/Eq0.37 EarningsAug 14 BMO Payout4.30% Avg Volume1.29M Price150.84
Recom1.80 SMA201.20% SMA501.93% SMA2000.54% Volume1,099,150 Change2.00%
15-May-14Reiterated Argus Buy $175 → $160
08-May-14Reiterated B. Riley & Co. Neutral $170 → $157
08-May-14Downgrade RBC Capital Mkts Top Pick → Outperform $187 → $160
03-Mar-14Reiterated UBS Buy $176 → $190
03-Mar-14Reiterated Stifel Buy $165 → $175
25-Feb-14Reiterated CRT Capital Buy $165 → $175
07-Feb-14Downgrade B. Riley & Co. Buy → Neutral
16-Jan-14Reiterated Argus Buy $160 → $175
07-Jan-14Initiated RBC Capital Mkts Top Pick $187
12-Dec-13Reiterated Stifel Buy $150 → $165
07-Nov-13Reiterated Argus Buy $152 → $160
04-Nov-13Reiterated UBS Buy $140 → $160
21-Oct-13Initiated Argus Buy $152
17-Sep-13Initiated CRT Capital Buy $145
30-Jul-13Reiterated B. Riley & Co. Buy $139 → $145
09-Jul-13Reiterated Canaccord Genuity Buy $128 → $140
25-Feb-13Upgrade UBS Neutral → Buy $115 → $130
12-Feb-13Reiterated Deutsche Bank Hold $110 → $115
04-Feb-13Upgrade Canaccord Genuity Hold → Buy $128
04-Feb-13Reiterated RBC Capital Mkts Sector Perform $109 → $111
14-Aug-14 06:36PM  Perrigo Regains Some Lost Ground On Fiscal Q4 Beat at Investor's Business Daily +7.29%
04:43PM  [video] U.S. Markets Close Higher, Red Robbin Serves Disappointing Earnings at TheStreet
04:37PM  Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving Benzinga
04:25PM  Stocks End With Small Gains; Amgen Shrugs Off Drug Data at Investor's Business Daily
01:15PM  Perrigo Beats on Q4 Earnings and Sales, Provides Guidance Zacks
01:05PM  Cohen, Point72 must face SAC insider trading lawsuit-judge Reuters
11:53AM  Why Perrigo (PRGO) Stock Is Rising Today at TheStreet
11:02AM  Perrigo Q4 Beats Estimates, But Guidance Misses at Investor's Business Daily
10:37AM  Plug Power rallies, GM drops on sell rating at MarketWatch
09:41AM  /C O R R E C T I O N -- Perrigo Company plc/ PR Newswire
07:52AM  Perrigo Company plc Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins PR Newswire
07:07AM  Q4 2014 Perrigo Company Earnings Release - Before Market Open CCBN
13-Aug-14 03:49PM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
12-Aug-14 10:06AM  5 Companies That Have Moved Overseas For Lower Taxes Benzinga
10-Aug-14 05:39PM  Benzinga Weekly Preview: US Airstrikes Likely To Wreak Havoc on Markets Benzinga
08-Aug-14 10:25AM  Wall Street Transcript Interview with Howard Zauberman, the President and CEO of Vision-Sciences, Inc. (VSCI) Wall Street Transcript
05-Aug-14 09:00AM  Introducing SENTRY® Petrodex® Advanced Dental Care Calming Kit for Dogs PR Newswire
31-Jul-14 08:58AM  Perrigo Company plc To Release Fourth Quarter And Fiscal Year 2014 Results On August 14, 2014 PR Newswire
30-Jul-14 08:10AM  Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray 0.25% PR Newswire
06:12AM  Bob Doll's Best Ideas: Believe In Meg Whitman, Be Wary Of GM at Forbes
28-Jul-14 12:35PM  Bankers push 'tax-dodge' M&A deals Reuters
25-Jul-14 12:48PM  [$$] Three Ways to Play the 'Inversion' Boom at The Wall Street Journal
24-Jul-14 12:56PM  Perrigo confirms AB therapeutic equivalent rating for testosterone gel 1.0% at theflyonthewall.com
12:55PM  Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% PR Newswire
22-Jul-14 07:11AM  #PreMarket Primer: Tuesday, July 22: Separatists Hand Over Remains From Malaysian Airlines Flight Benzinga
21-Jul-14 12:00AM  Perrigo, Actelion Tax Targets Abroad for U.S. Drugmakers at Bloomberg
15-Jul-14 12:57PM  Why Perrigo (PRGO) Stock Is Falling Today at TheStreet
12:34PM  Israel Stocks Climb to Three-Week High Amid Perrigo Deal Report at Bloomberg
11:13AM  Perrigo retreats after analyst sees limited potential buyers at theflyonthewall.com
11:05AM  Perilous Reversal Stock: Perrigo (PRGO) at TheStreet
04:23AM  Israel Stocks Head to 3-Week High Amid Perrigo Deal Report at Bloomberg
14-Jul-14 03:01PM  Stocks On Pace For Second Gain; Kandi Keeps Soaring at Investor's Business Daily +8.69%
10:55AM  Trade-Ideas: Perrigo (PRGO) Is Today's "Barbarian At The Gate" Stock at TheStreet
10:38AM  Perrigo move higher attributed to circulation of Globes report at theflyonthewall.com
11-Jul-14 01:03PM  3 Stocks Pulling The Health Care Sector Downward at TheStreet
09-Jul-14 11:14AM  Salix Pharma Stock Falls Despite Tax-Inversion Deal at Investor's Business Daily
08-Jul-14 05:32PM  Ireland: U.S. Tax Inversions Aren't Helping Us Much Either at The Wall Street Journal
08:47AM  Perrigo Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg PR Newswire
04:39AM  Israeli Stocks Sink to 2-Month Low as Bonds Drop on Gaza Attack at Bloomberg
07-Jul-14 04:58PM  More U.S. companies doing deals to avoid U.S. taxes - Congress study Reuters
23-Jun-14 11:00AM  Perrigo Settles Patent Dispute with Teva Zacks
11:00AM  Perrigo Settles Patent Dispute with Teva
20-Jun-14 03:19PM  Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does at Seeking Alpha
03:19PM  Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does
09:20AM  Perrigo Announces Settlement In Proair® HFA Patent Case PR Newswire
09:20AM  Perrigo Announces Settlement In Proair® HFA Patent Case
08:00AM  Shocking Prediction: This Little-Known Wal-Mart Supplier Could Double Again StreetAuthority Network
08:00AM  Shocking Prediction: This Little-Known Wal-Mart Supplier Could Double Again
18-Jun-14 08:00AM  Shocking Prediction: This Little-Known Wal-Mart Supplier Could Double Again StreetAuthority Network
17-Jun-14 01:58PM  [$$] 2 Stocks Riding the Preventive-Care Wave at Barrons.com
01:58PM  [$$] 2 Stocks Riding the Preventive-Care Wave
16-Jun-14 10:14PM  Shocking Prediction: This Little-Known Wal-Mart Supplier Could Double Again StreetAuthority Network
10:13AM  [video] Medical M&A: Who's next? at CNBC
10:13AM  [video] Medical M&A: Who's next?
13-Jun-14 02:00PM  Already Up 438%, This 'Secret' Health Care Giant Could Still Double StreetAuthority Network
02:00PM  Already Up 438%, This 'Secret' Health Care Giant Could Still Double
11-Jun-14 10:07AM  Perrigo Can Reach $200 If It Keeps Tysabri Royalties, Lot More If It Sells Them at Seeking Alpha
10:07AM  Perrigo Can Reach $200 If It Keeps Tysabri Royalties, Lot More If It Sells Them
06-Jun-14 03:30PM  Alkermes' Pipeline Holds Promise Zacks
01:34PM  Joseph Papa, A Generic CEO With Brand-Name Action at Investor's Business Daily
01:34PM  Joseph Papa, A Generic CEO With Brand-Name Action
03-Jun-14 01:03PM  PRGO, VRX And BIIB, Pushing Drugs Industry Downward at TheStreet
01:03PM  PRGO, VRX And BIIB, Pushing Drugs Industry Downward
30-May-14 08:09AM  Perrigo Company plc To Present At Jefferies 2014 Global Healthcare Conference PR Newswire
08:09AM  Perrigo Company plc To Present At Jefferies 2014 Global Healthcare Conference
06:00AM  Jim Cramer's Top Stock Picks: PLKI MKTO FUEL RUBI PRGO AAPL at TheStreet
29-May-14 08:11PM  Jim Cramer's 'Mad Money' Recap: Which Food Stock Will Be Bought Next? at TheStreet
07:56PM  Jim Cramer's 'Mad Money' Recap: Which Food Stock Will Be Bought Next? at TheStreet
27-May-14 01:02PM  3 Health Care Stocks Dragging The Sector Down at TheStreet
22-May-14 11:27AM  Catalyst For Perrigo: Sale Of Tysabri Royalties at Seeking Alpha
15-May-14 01:55PM  Perrigo weakness creates buying opportunity, says Argus at theflyonthewall.com
12-May-14 09:25AM  Perrigo announces FDA approval of generic version of Astepro nasal spray at theflyonthewall.com
09:23AM  Perrigo Company plc Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray PR Newswire
11-May-14 05:36AM  Allergan Can Buy Perrigo To Avoid Valeant at Seeking Alpha
08-May-14 09:24AM  Will This Downgrade Hurt Perrigo (PRGO) Stock Today? at TheStreet
08:55AM  Perrigo downgraded to Outperform from Top Pick at RBC Capital at theflyonthewall.com
07:48AM  Perrigo downgraded to Neutral from Buy at Buckingham at theflyonthewall.com
07:19AM  Perrigo downgraded by RBC Capital Mkts Briefing.com
07-May-14 07:02PM  Perrigo missed EPS views Investor's Business Daily -8.70%
04:00PM  Perrigo Public Limited's (PRGO) CEO Joseph Papa on Q3 2014 Results - Earnings Call Transcript at Seeking Alpha
01:15PM  Perrigo Misses on Earnings and Sales, Outlook Slashed Zacks
12:32PM  Midday movers: Datalink, Herbalife, Merck & More at CNBC
11:15AM  Aegerion, Perrigo, Corcept all tumble on rough earnings, difficult news at MarketWatch
10:23AM  PERRIGO CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
09:16AM  [$$] Perrigo Profit Falls on Restructuring Expenses at The Wall Street Journal
08:00AM  Perrigo Company plc Reports Record Quarterly Revenue and Adjusted Operating Income Despite Weak Retail and Cough, Cold and Flu Seasons PR Newswire
07:07AM  Q3 2014 Perrigo Company Earnings Release - Before Market Open CCBN
06-May-14 04:00PM  Is Perrigo (PRGO) Poised to Beat Earnings Estimates? Zacks
05-May-14 07:39AM  The Zacks Analyst Blog Highlights: Pfizer, Allergan, Mallinckrodt, Perrigo and Sallie Mae Zacks
02-May-14 02:11PM  AstraZeneca Nixes New Bid As Pfizer Woos British PM at Investor's Business Daily
30-Apr-14 01:39PM  Hospira Beats on Earnings & Sales, View Maintained Zacks
28-Apr-14 06:58PM  Pfizer move to join tax-driven deal-making raises red flags in U.S Reuters
03:13PM  Faster FDA Approvals and Paradigm-Shifting Breakthroughs Boost Pharma Stocks: Citigroup Investment Global Head of Healthcare Research & Analysis Andrew Baum, M.D. Interviews with the Wall Street Transcript Wall Street Transcript
02:30PM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
01:53PM  Generic Drugs as Market Disruptors: Why CVS, Perrigo Will Benefit at Minyanville
09:00AM  PetArmor® Encourages Americans to Honor K-9 Officers During "National Thank a Police Dog Week" PR Newswire
23-Apr-14 11:00AM  The Country's Largest Pension Fund Is Buying These 3 Stocks StreetAuthority Network
11:00AM  3 Stocks The Country's Largest Pension Fund Is Buying StreetAuthority Network
09:14AM  Perrigo Company plc To Release Third Quarter Fiscal Year 2014 Results On May 7, 2014 PR Newswire
22-Apr-14 06:45PM  Asian Futures Rise as U.S. Extends Climb; Oil Holds Drop at Bloomberg
Perrigo Company Public Limited Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API) primarily in the United States, Israel, the United Kingdom, Mexico, and Australia. Its Consumer Healthcare business offers various OTC and nutrition products, including analgesics, cough and cold remedies, and gastrointestinal and feminine hygiene products, as well as vitamins, dietary supplements, and nutritional drinks. The company's Nutritionals business develops, manufactures, markets, and distributes infant formula, pediatric nutritionals and vitamins, minerals, and supplements primarily under the Centrum, One-A-Day, Flintstones, and Osteo-Bi-Flex brands. Its Rx Pharmaceuticals business develops, manufactures, and markets a portfolio of generic prescription drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, and oral liquids and oral solid dosage forms. The company's Active Pharmaceutical Ingredients (API) business develops, manufactures, and markets differentiated APIs and finished dosage forms for the branded and generic pharmaceutical industries. In addition, Perrigo Company Public Limited Company is developing TYSABRI for the treatment of multiple sclerosis and crohn's disease; and ELND005 for the treatment of Alzheimer's disease and bipolar disorder. Its Pharmaceutical and Medical Diagnostic Products business markets and manufactures branded prescription drugs under licenses; and imports other pharmaceutical and medical diagnostic products. The company sells its products to drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. Perrigo Company Public Limited Company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PAPA JOSEPH CPresident and CEODec 12Option Exercise48.5615,000728,401125,506Dec 16 04:30 PM
PAPA JOSEPH CPresident and CEODec 12Sale150.1215,0002,251,819116,655Dec 16 04:30 PM
COHEN GARY MDirectorDec 12Sale152.524,632706,47311,868Dec 16 04:27 PM
JANDERNOA MICHAEL JDirectorDec 09Sale154.9768,62010,634,213120,552Dec 10 03:54 PM
JANDERNOA MICHAEL JDirectorDec 06Sale155.6760,0009,339,918148,000Dec 10 03:54 PM
Yu LouisExecutive VP Global QualityDec 05Sale155.227010,8655,420Dec 09 03:06 PM
Yu LouisExecutive VP Global QualityNov 25Sale155.512,292356,4228,548Nov 26 02:47 PM
KINGMA TODD WExecutive VP, General CounselNov 22Sale154.976,5001,007,3123,000Nov 26 02:48 PM
Brown Judy LExecutive VP & CFONov 21Sale154.749,9881,545,5630Nov 22 02:47 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyNov 20Sale152.808,4001,283,5440Nov 22 02:38 PM
Kochan SharonExecutive VP U.S. GenericsNov 15Sale152.5345569,4015,086Nov 19 02:54 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyNov 12Option Exercise90.654,518409,5572,259Nov 14 02:45 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyNov 12Sale150.004,518677,7000Nov 14 02:45 PM
JANDERNOA MICHAEL JDirectorNov 07Sale144.34755108,973868Nov 12 06:30 PM
Gottfried RanDirectorNov 04Option Exercise89.422,275203,43113,884Nov 06 10:27 AM
Gottfried RanDirectorNov 04Sale143.362,275326,15111,609Nov 06 10:27 AM
Brown Judy LExecutive VP & CFOOct 01Option Exercise30.061,41642,56518,849Oct 02 04:13 PM
Brown Judy LExecutive VP & CFOOct 01Sale123.421,416174,76217,433Oct 02 04:13 PM
PAPA JOSEPH CPresident and CEOSep 24Option Exercise35.8515,000537,750131,655Sep 26 10:11 AM
PAPA JOSEPH CPresident and CEOSep 24Sale124.6015,0001,869,015116,655Sep 26 10:11 AM
HENDRICKSON JOHN TEVP Global Operations & SupplySep 18Option Exercise58.822,161127,1102,161Sep 19 05:08 PM
HENDRICKSON JOHN TEVP Global Operations & SupplySep 18Sale125.002,161270,1250Sep 19 05:08 PM
Stewart Michael RobertSr. VP Global Human ResourcesSep 11Option Exercise86.873,208278,6741,121Sep 13 03:40 PM
Stewart Michael RobertSr. VP Global Human ResourcesSep 11Sale123.375,063624,6360Sep 13 03:40 PM
Yu LouisExecutive VP Global QualitySep 09Option Exercise58.821,852108,93512,692Sep 11 03:36 PM
Yu LouisExecutive VP Global QualitySep 09Sale124.111,852229,85210,840Sep 11 03:36 PM
HENDRICKSON JOHN TEVP Global Operations & SupplySep 06Sale123.461,000123,45518,279Sep 10 03:56 PM
HENDRICKSON JOHN TEVP Global Operations & SupplySep 04Sale123.922,000247,83120,279Sep 06 10:42 AM
Brown Judy LExecutive VP & CFOSep 03Option Exercise30.062,50075,15019,933Sep 05 01:22 PM
Jamison Scott FExecutive Vice President PBMSep 03Sale122.1278095,2542,799Sep 05 01:24 PM
Brown Judy LExecutive VP & CFOSep 03Sale122.072,500305,16717,433Sep 05 01:22 PM
Needham JeffreySr. VP Commercial Business DevAug 30Option Exercise76.083,613274,8727,158Sep 04 12:22 PM
Needham JeffreySr. VP Commercial Business DevAug 30Sale120.476,585793,2955,199Sep 04 12:22 PM
Kochan SharonExecutive VP U.S. GenericsAug 29Option Exercise58.821,32377,8196,864Sep 03 01:21 PM
Kochan SharonExecutive VP U.S. GenericsAug 29Sale120.983,467419,4435,541Sep 03 01:21 PM
PAPA JOSEPH CPresident and CEOAug 27Option Exercise35.8515,000537,750133,455Aug 29 02:37 PM
PAPA JOSEPH CPresident and CEOAug 27Sale117.6415,0001,764,590118,455Aug 29 02:37 PM
Brown Judy LExecutive VP & CFOAug 26Sale119.283,424408,40717,433Aug 27 04:01 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 26Sale119.152,099250,1030Aug 27 04:02 PM
Farrington ThomasSenior VP and CIOAug 26Sale119.30937111,7841,040Aug 27 04:03 PM